» Articles » PMID: 7634380

Taxol Cytotoxicity on Human Leukemia Cell Lines is a Function of Their Susceptibility to Programmed Cell Death

Overview
Specialty Oncology
Date 1995 Jan 1
PMID 7634380
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Taxol is the prototype of a class of antineoplastic drugs that target microtubules. It enhances tubulin-monomer polymerization and stabilizes tubulin polymers, increasing the fraction of cells in the G2 or M phase of the cell cycle. We report that treatment of HL-60 and U937 myeloid cell lines with 1-10 microM taxol induces DNA fragmentation and the appearance of morphological features consistent with the process of apoptosis. Taxol-induced apoptosis is inhibited neither by cycloheximide nor by actinomycin D and therefore appears to be independent of new protein synthesis. Taxol causes arrest in the G2 phase of the cell cycle and affects cell viability but does not induce DNA fragmentation in the K562 erythromyeloid cell line. Protein-synthesis inhibitors, colcemid, ionomycin, and starvation, known to trigger apoptosis, proved ineffective as well. These results suggest that the antineoplastic effect of taxol is mediated in susceptible cell lines by induction of the apoptotic machinery and that K562 partial resistance may depend upon the intrinsic inability of these tumor cells to undergo apoptosis.

Citing Articles

Arrest and Attack: Microtubule-Targeting Agents and Oncolytic Viruses Employ Complementary Mechanisms to Enhance Anti-Tumor Therapy Efficacy.

De S, Ehrlich M Genes (Basel). 2024; 15(9).

PMID: 39336785 PMC: 11431212. DOI: 10.3390/genes15091193.


Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages.

Zeng Q, Yang F, Li C, Xu L, He X, Mai F Front Immunol. 2019; 10:72.

PMID: 30761140 PMC: 6361797. DOI: 10.3389/fimmu.2019.00072.


Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.

Zheng H, Zeltsman M, Zauderer M, Eguchi T, Vaghjiani R, Adusumilli P Immunotherapy. 2018; 9(11):913-927.

PMID: 29338609 PMC: 5810850. DOI: 10.2217/imt-2017-0052.


Properties of cells through life and death - an acoustic microscopy investigation.

Pasternak M, Strohm E, Berndl E, Kolios M Cell Cycle. 2015; 14(18):2891-8.

PMID: 26178635 PMC: 4825614. DOI: 10.1080/15384101.2015.1069925.


Increased Protein Tyrosine Phosphorylation in Apoptotic Neural Cell Death Due to Microtubule Perturbations.

Chromy B, Lambert M, Klein W Neurotox Res. 2014; 2(4):357-372.

PMID: 25242875 PMC: 4167016. DOI: 10.1007/BF03033343.


References
1.
Rowinsky E, Cazenave L, Donehower R . Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst. 1990; 82(15):1247-59. DOI: 10.1093/jnci/82.15.1247. View

2.
Clarke A, Purdie C, Harrison D, Morris R, Bird C, Hooper M . Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 1993; 362(6423):849-52. DOI: 10.1038/362849a0. View

3.
Bhalla K, Ibrado A, Tourkina E, Tang C, Mahoney M, Huang Y . Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia. 1993; 7(4):563-8. View

4.
Barry M, Behnke C, Eastman A . Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol. 1990; 40(10):2353-62. DOI: 10.1016/0006-2952(90)90733-2. View

5.
Diomede L, Colotta F, Piovani B, Re F, MODEST E, Salmona M . Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int J Cancer. 1993; 53(1):124-30. DOI: 10.1002/ijc.2910530123. View